Agilent Technologies, Inc.

Valuation Analysis

About the Company

Agilent Technologies, Inc. en bref

Agilent Technologies, Inc. (A) is currently trading at 110,93 € with a market capitalization of 31,3 Md €. The trailing P/E ratio stands at 25.52x, with a forward P/E of 19.24x. The 52-week range spans from 94,55 € to 139,86 €; the current price is 20.7% below the yearly high. Year-over-year revenue growth stands at +10.0%. The net profit margin stands at 19.55%.

💰 Dividende

Agilent Technologies, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

17 analystes évaluent Agilent Technologies, Inc. (A) au consensus : Acheter. L'objectif de cours moyen est de 139,93 €, soit un potentiel de +26.15% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 125,67 € à 161,45 €.

Agilent Technologies, Inc. : la thèse d'investissement en détail

Agilent Technologies, Inc. (A) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 10% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 60% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 52.64% gross margin and 23.71% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat.

Valorisation en contexte

The PEG ratio at 1.26 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 19.24x is meaningfully below the trailing 25.52x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 26.15% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility.

Trading Data

Related Stocks in the Same Sector

Where can I buy Agilent Technologies, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.